Lipoprotein lipase protects bovine endothelial cells from human NK cytotoxic activity

Cellular Immunology

Volumn 227, Issue 1, 2004, Pages 59-69

  De Sanctis, Juan B ^a   Arciniegas, Enrique ^b   Bianco, Nicolás E ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

CD40; Endothelial cells; Lipoprotein lipase; Lymphokine activated killer cells; NK cells; Xenograft rejection

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; HEPARAN SULFATE; HYBRID PROTEIN; INDOMETACIN; LIPOPROTEIN LIPASE; WORTMANNIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CATTLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; LUNG ENDOTHELIUM; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, SURFACE; CATTLE; CYCLOOXYGENASE INHIBITORS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HEPARITIN SULFATE; HUMANS; INDOMETHACIN; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LIPOPROTEIN LIPASE; MALE; RECOMBINANT FUSION PROTEINS;

BOVINAE;

EID: 1642283085     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.02.001     Document Type: Article

References (32)

1. Braun J.E.A., Severson D.L. Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem. J. 287:1992;337-347.
2. Mead J.R., Ramji D.P. The pivotal role of lipoprotein lipase in atherosclerosis. Cardiovasc. Res. 55:2002;261-269.
3. De Sanctis J.B., Blanca I., Radzioch D., Bianco N.E. Lipoprotein lipase expression in natural killer cells and its role in their cytotoxic activity. Immunology. 83:1994;232-239.
4. Jaye M., Lynch K.J., Krawiec J., Marchadier D., Maugeais C., Doan K., South V., Amin D., Perrone M., Rader D.J. A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21:1999;424-428.
5. McCoy M.G., Sun G.S., Marchadier D., Maugeais C., Glick J.M., Rader D.J. Characterization of the lipolytic activity of endothelial lipase. J. Lipid Res. 43:2002;921-929.
6. De Sanctis J.B., Blanca I., Bianco N.E. Regulatory effects of lipoprotein lipase on proliferative and cytotoxic activity of NK cells. J. Lipid Res. 37:1996;1987-2000.
7. Renier G., Skamene E., De Sanctis J.B., Radzioch D. High macrophage lipoprotein lipase is correlated in inbred strains with susceptibility to atherosclerosis. Arterioscler. Thromb. 13:1993;190-196.
8. De Sanctis J.B., Blanca I., Radzioch D., Bianco N.E. Lipoprotein metabolism and NK function. Recent Res. Dev. Immunol. 1(Part II):1999;483-496.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 326:1993;801-809.
10. Renier G., Skamene E., De Sanctis J.B., Radzioch D. Induction of tumor necrosis factor α gene expression by lipoprotein lipase. J. Lipid Res. 35:1994;271-278.
11. Renier G., Oliver M., Skamene E., Radzioch D. The induction of tumor necrosis factor α gene expression by lipoprotein lipase requires protein kinase C. J. Lipid Res. 35:1994;1413-1421.
12. Trinchieri G. The biology of NK cells. Adv. Immunol. 47:1989;187-487.
13. Yokoyama W.M., Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3:2003;304-316.
14. De Sanctis J.B., Blanca I., Bianco N.E. Expression of different lipoprotein receptors in NK cells and their role on NK proliferative and cytotoxic activity. Immunology. 86:1995;399-407.
15. Schneider M.K., Forte P., Seebach J.D. Adhesive interactions between human NK cells and porcine endothelial cells. Scand. J. Immunol. 54:2001;70-75.
16. Horvarh-Arcidiacono J.A., Tsuyuki S., Mostowski H., Bloom E.T. Human natural killer cell activity against porcine targets: modulation by control of the oxidation-reduction environment and role of adhesion molecule interactions. Cell Immunol. 222:2003;35-44.
17. Schneider M.K., Strasser M., Gilli U.O., Kocher M., Moser R., Seebach J.D. Rolling and adhesion of human NK cells to porcine endothelial cells mainly relies on CD49d-CD106 interactions. Transplantation. 75:2003;789-796.
18. Laumonier T., Walpen A.J., Maurus C.F., Mohacsi P.J., Matozan K.M., Korchagina E.Y., Bovin N.V., Vanhove B., Seebach J.D., Rieben R. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells. Transplantation. 76:2003;838-843.
19. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 67:2000;2-17.
20. Carbone E., Ruggiero G., Tarrazano G., Palomba C., Manzo C., Fontana S., Spits H., Karre K., Zappacosta S. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185:1997;2053-2060.
21. Jyothi M.D., Khar A. Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon gamma: its role in the elicitation of an effective antitumor response. Cancer Immunol. Immunother. 49:2000;563-572.
22. Sartorius R., D'Apice L., Barba P., Guardiola J., Santoni A., Velotti F., De Bernardis P. Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells. Cell Immunol. 221:2003;81-88.
23. Padmore L., An S., Gunby R.H., Kelly K., Radda G.K., Knox K.A. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line. Cell Immunol. 177:1997;119-128.
24. Deregibus M.C., Buttiglieri S., Russo S., Bussolati B., Camussi G. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J. Biol. Chem. 278:2003;18008-18014.
25. Reiners M.E.J., Sho M., Robertson S.W., Geehan C.S., Briscoe D.M. Proangiogenic function of CD40 ligand-CD40 interactions. J. Immunol. 171:2003;1534-1541.
26. Dongai-Bagtzoglu A.I., Thienel U., Yellin M.J. CD40 ligation triggers COX-2 expression in endothelial cells: evidence that CD40-mediated IL-6 synthesis is COX-2 dependent. Inflamm. Res. 52:2003;18-25.
27. Arciniegas E., Becerra A., De Sanctis J.B., Graterol A., Ramírez R. CD40 and CD40L expression in the chicken embryo aorta. Possible role in the endothelial mesenchymal transdifferentiation process. Anat. Rec. 274A:2003;942-951.
28. Ochoa M., Blanca I., Rodríguez A., Bianco N.E., De Sanctis J.B. A monoclonal antibody against human lipoprotein lipase that recognizes the murine and bovine counterparts. Med. Sci. Res. 26:1998;119-120.
29. Graterol A., Arciniegas E., De Sanctis J.B. Endothelial cells scraped from the luminal surface of bovine pulmonary artery give rise to nonmuscle cells. Microvasc. Res. 60:2000;1-7.
30. Timonen T., Ortaldo J.R., Herberman R.B. Characteristics of human large granular lymphocytes and relationship to natural killer cells and K cells. J. Exp. Med. 153:1981;569-571.
31. Krieglstein C.F., Granger D.N. Adhesion molecules and their role in vascular disease. Am. J. Hypertens. 14(6 Part 2):2001;44S-54S.
32. Lider O., Cahalon L., Gilat D., Hershkoviz R., Siegel D., Margalit R., Shosevoy O., Cohen I.R. A disaccharide that inhibits tumor necrosis factor α is formed from the extracellular matrix by the enzyme heparanase. Proc. Natl. Acad. Sci. USA. 92:1995;5037-5041.